RILEE COMO: Open Payments
NPI 1619730207 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,223 in 56 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $1,072 · 2025 $1,223
Food & beverage: $1,223
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 23 | $487 |
| Ardelyx, Inc. | 20 | $340 |
| Intercept Pharmaceuticals, Inc. | 6 | $192 |
| Janssen Biotech, Inc. | 1 | $86 |
| Ipsen Biopharmaceuticals, Inc | 4 | $84 |
| Madrigal Pharmaceuticals | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
Products named: IBSRELA, OCALIVA, TREMFYA, IQIRVO, Epclusa, Bylvay, REZDIFFRA, Wegovy.
Industry payments across LA — which companies pay providers there.
